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Commentary: Ganglion cell complex 
of retinal layer thickness by optical 
coherence tomography in cases of 
multiple sclerosis without optic 
neuritis compared to healthy eyes
Peripapillary	retinal	nerve	fiber	layer	(pRNFL)	thickness	can	
be	non‑invasively	measured	by	optical	coherence	tomography	
(OCT).	This	has	been	 considered	 as	 a	 strong	biomarker	 of	
axonal	degeneration	in	multiple	sclerosis	(MS).	This	testing	is	
also	relatively	inexpensive	and	less	time	consuming	compared	
to	magnetic	resonance	imaging.	With	increase	in	the	number	of	
disease	modifying	therapies	for	MS	OCT	can	serve	as	a	good	
biomarker	to	describe	the	stability	or	progression	of	the	disease.
On	 an	 average	 it	 is	 believed	 that	 pRNFL	decreases	 by	
1‑2	µm	per	year	 in	MS	according	 to	 some	 studies.[1,2] Also 
the	pRNFL	has	been	shown	to	be	thinner	in	progressive	MS	
compared	 to	 stable	 relapsing	 remitting	MS.[3]	Optic	neuritis	
in	MS	can	 lead	 to	pRNFL	 thinning	a	 few	months	 later	due	
to	 retrograde	 axonal	 degeneration	 and/or	 trans‑synaptic	
degeneration.[4,5] However, the pathophysiology underlying 
pRNFL	thinning	in	MS	without	optic	neuritis	is	not	entirely	
understood.	This	might	suggest	an	ongoing	neurodegenerative	
process.[3]	Achievement	of	no	 evident	disease	 activity	with	
disease‑modifying	treatment	in	MS	has	been	associated	with	
less	marked	atrophy	of	the	pRNFL	longitudinally.
The	previous	time	domain	OCT‑based	studies	in	MS	also	
demonstrated	 that	 there	 is	atrophy	of	 the	pRNFL.	With	 the	
spectral	 domain	OCT	 that	 has	 a	much	higher	 resolution,	
automated segmentation of the individual retinal layers and 
analysis	of	 their	 thickness	 is	possible.	Five	of	 the	10	 retinal	
layers	have	been	analyzed	systematically	 in	MS	besides	 the	
RNFL:	Ganglion	cell	layer	(GCL),	inner	plexiform	layer	(IPL),	
inner	nuclear	 layer	 (INL),	 outer	plexiform	 layer	 (OPL),	 and	
outer	nuclear	layer	(ONL).
According	 to	 a	meta	 analysis[6] that studied the retinal 
layer	 segmentation	 in	MS,	 pRNFL	 thinning	was	 seen	 in	
multiple	sclerosis	with	optic	neuritis	(MSON)	(mean	difference	
–20·10	µm,	95%	CI,	range	–22·76	to	–17·44; P <	0·0001)	and	in	
multiple	 sclerosis	without	 optic	 neuritis	 (MSNON)	 (mean	
difference	–7·41	µm,	range	–8·98	to	–5·83; P <	0·0001)	compared	
to	controls.	In	contrast,	the	present	manuscript	that	studied	MS	
without	optic	neuritis	in	ARAB	patients	found	no	difference	
in	the	pRNFL	in	MSNON	and	control	subjects.		However,	the	
authors	already	 identified	 the	 limitations	of	 this	 study	as	 it	
was	a	cross	sectional,	and	thus	a	longitudinal	study	may	be	
necessary	for	assessment.
The meta analysis[6]	 also	demonstrated	 that	 besides	 the	
pRNFL,	macular	RNFL	also	 showed	 thinning	of	 –6·18	µm 
(range	–8·07	to	–4·28; P <	0·0001)	in	MSON	eyes	and	thinning	
of	–2·15	µm	(range	–3·15	to	–1·15; P <	0·0001)	in	MSNON	eyes	
compared	to	controls. Similarly,	the	present	manuscript	has	
also	noted	macular	RNFL	thinning	in	MSNON	eyes	compared	
to	controls.	They	additionally	looked	at	superior	and	inferior	
macular	thinning	individually	in	MSNON	and	felt	that	both	
were	thinner	compared	to	controls.
Macular	ganglion	cell	layer	and	inner	plexiform	layer	(GCIPL)	
atrophy	was	 described	 in	 the	meta	 analysis[6]	 for	MSON	
eyes	(–16·42	µm)	and	MSNON	eyes	(–6·31	µm)	compared	to	
controls.	This	manuscript	also	showed	that	the	mean	thickness	
of	 the	macular	GCIPL	 (described	as	ganglion	 cell	 complex	
GCIPL)	was	thinner	 in	MSNON	compared	to	controls.	Also	
interestingly,	the	mean	ganglion	cell	complex	(GCIPL)	and	total	
GCL++	thickness	(thickness	of	GCL	+	IPL	+	nerve	fiber	layer)	
in	the	superior	macula	in	MSNON	group	was	thinner	than	the	
control	group.	Hence,	superior	macula	seems	most	affected	in	
MSNON	as	per	this	manuscript.
Atrophy	of	retinal	layers	in	MS	stops	at	the	inner	nuclear	
layer.[6]	Consequently,	volume	changes	of	the	INL	have	emerged	
as	a	potentially	new	surrogate	for	inflammation‑related	changes	
in	MS	and	also	for	studying	response	to	immune	therapy.[7] The 
degree	of	inner	retinal	layer	(RNFL,	GCIPL)	atrophy	is	most	
marked	in	the	early	disease	course.	This	finding	has	also	been	
reflected	in	the	present	study.
Most	 of	 the	 published	 data	 have	 described	 the	OCT	
findings	seen	 in	western	MS	population.	However	with	MS	
now	being	prevalent	 in	 the	Gulf	 countries,	 this	manuscript	
has	served	an	important	purpose	of	describing	OCT	findings	
in	the	non‑western	population.	Most	of	it	correlates	with	that	
described	in	western	MS	patients.
Therefore	with	 all	 the	 available	 evidence,	 it	 is	 apparent	
that	OCT	 should	 be	 included	 as	 a	 routine	 procedure	 in	
monitoring	MS.	It	serves	several	purposes	such	as	monitoring	
for neurodegeneration,[2,8] for distinguishing progressive from 
stable	relapsing	remitting	MS	and	also	for	studying	response	
to	disease	modifying	therapy	longitudinally.
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